FDA and US officials target potent kratom products amid safety concerns

The FDA is targeting 7-hydroxymitragynine (7-OH), a potent, morphine-like compound found in kratom, which has gained popularity for its pain-relieving and mood-enhancing effects. While some advocate for its benefits, concerns about its high potency, potential for addiction, and unregulated production have led to calls for stricter regulation to ensure safety. Kratom's legal status varies across states, and the compound's effects are not fully understood, raising public health concerns.